Abstract
Cyanobacteria have been implicated in the etiology of ALS for the past 50 years. The weakness of the theories of cyanobacteria or its neurotoxin, BMAA as the etiologic agent in ALS is the iniquitousness of cyanobacteria in the environment. In third world countries, clean water is far from commonplace, the exposure to cyanobacteria higher, yet the incidence of ALS is probably less than it is in developed countries. Even in the developed world, exposure to cyanobacteria is commonplace. Differences in the gut microbiome, possibly the presence of Proteobacteria, a protective agent against cyanobacteria toxins, may be important.
Author Contributions
Copyright© 2017
F. Baugh Reginald.
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Competing interests The authors have declared that no competing interests exist.
Funding Interests:
Citation:
Introduction
High incidence of amyotrophic lateral sclerosis (ALS) occurred among the Chamorro natives in Guam back in the 1940s and 1950s, leading scientists to link cyanobacteria and one of its neurotoxin, beta-N-methyl amino-L-alanine (BMAA) to ALS. Subsequent findings of the regular biosynthesis of BMAA in the Baltic Sea combined with its possible transfer and bioaccumulation within major food webs, some ending in human consumption, has been alarming